Hanarbe 20 mg

Hanarbe 20 mg is a medicine authorised by Swissmedic under authorisation number 69936. The authorisation holder is Hasten Biopharmaceutic (Switzerland) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 August 2024 and the authorisation is valid without a time limit. ATC code C09CA09 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 69936
  • ATC C09CA09
  • Synthetic medicines
Authorisation data
Authorisation number69936
NameHanarbe 20 mg
Full nameHanarbe 20 mg, Tabletten
Authorisation holderHasten Biopharmaceutic (Switzerland) AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09CA09
First authorisation08 August 2024
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Hanarbe 20 mg, TablettenB08 August 2024
2Hanarbe 40 mg, TablettenB08 August 2024
3Hanarbe 80 mg, TablettenB08 August 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Tablette(n)C09CA0902.07.1.B
298Tablette(n)C09CA0902.07.1.B
314Tablette(n)C09CA0902.07.1.B
428Tablette(n)C09CA0902.07.1.B
598Tablette(n)C09CA0902.07.1.B
614Tablette(n)C09CA0902.07.1.B
728Tablette(n)C09CA0902.07.1.B
898Tablette(n)C09CA0902.07.1.B
914Tablette(n)C09CA0902.07.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Hanarbe 20 mg authorised in Switzerland?

Yes. Hanarbe 20 mg is authorised by Swissmedic under authorisation number 69936, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Hanarbe 20 mg have?

Hanarbe 20 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Hanarbe 20 mg?

The authorisation holder is Hasten Biopharmaceutic (Switzerland) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com